SRTS · Sensus Healthcare, Inc.
$2.86
-0.30 (-9.49%)
At close · Aug 14
Market Cap
$47.08M
Shares
16.46M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Joseph Sardano | Chief Executive Officer | $1,417,860 |
| Michael Sardano | President, General Counsel, Chief Commercial Officer, & Corporate Secretary | $1,213,917 |
| Javier Rampolla | Chief Financial Officer | $752,710 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Michael Sardano | President, General Counsel, & Corporate Secretary | $1,275,078 |
| Joseph Sardano | Chief Executive Officer | $1,268,030 |
| Javier Rampolla | Chief Financial Officer | $656,045 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Joseph Sardano | Chief Executive Officer | $687,599 |
| Michael Sardano | President, General Counsel, & Corporate Secretary | $452,523 |
| Javier Rampolla | Chief Financial Officer | $357,062 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Joseph Sardano | Chief Executive Officer | $754,428 |
| Javier Rampolla | Chief Financial Officer | $439,144 |
| Michael Sardano | President, General Counsel, & Corporate Secretary | $404,739 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Joseph Sardano | Chief Executive Officer | $628,451 |
| Javier Rampolla | Chief Financial Officer | $430,732 |
| Michael Sardano | President, General Counsel, & Corporate Secretary | $426,973 |
| Stephen Cohen | Executive VP, Strategic Initiatives and Dermatology Sales | $409,382 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Joseph Sardano | Chief Executive Officer | $510,006 |
| Stephen Cohen | Executive VP, Strategic Initiatives and Dermatology Sales | $435,737 |
| Michael Sardano | Vice President & General Counsel | $261,072 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Stephen Cohen | Executive VP, Strategic Initiatives and Dermatology Sales | $521,260 |
| Joseph Sardano | Chief Executive Officer | $466,800 |
| Arthur Levine | Chief Financial Officer | $284,448 |
| Michael Sardano | Vice President & General Counsel | $228,859 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Arthur Levine | Chief Financial Officer | $584,600 |
| Joseph Sardano | Chief Executive Officer | $538,392 |
| Stephen Cohen | Executive VP, Strategic Initiatives and Dermatology Sales | $478,617 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Larry Biscotti | Class I director | Appointed | 2026-01-12 |
| Eric Sachetta | Class II director | Appointed | 2025-11-13 |
| Dr. John Heinrich | director | Resigned | 2024-05-31 |
| Samuel O'Rear | director | Retired | 2024-02-02 |
| Michael Sardano | director | Appointed | 2024-01-18 |
| Javier Rampolla | Chief Financial Officer | Appointed | 2023-06-06 |
| Magdalena Martinez | Chief Operating Officer | Appointed | 2023-01-09 |
| Stephen Cohen | Executive Vice President, Strategic Initiatives and Dermatology | Resigned | 2022-01-31 |
| Joseph C. Sardano | President | Resigned | 2022-01-31 |
| Michael J. Sardano | President | Appointed | 2022-01-31 |